Zobrazeno 1 - 10
of 22
pro vyhledávání: '"David G. Wong"'
Autor:
Michael J. Schoenfeld MA, Emily F. Shortridge PhD, Steven C. Gelwicks MS, Zhanglin Cui PhD, David G. Wong MD
Publikováno v:
American Journal of Men's Health, Vol 8 (2014)
This study examined treatment patterns and patient characteristics of men initiating alpha adrenergic blocker therapy (alpha-blocker) for benign prostatic hyperplasia (BPH). The 2009 Thomson Reuters MarketScan® Database was used to identify the newl
Externí odkaz:
https://doaj.org/article/17df4eee2a20415f985aa409774b7867
Autor:
David G. Wong, Kathryn B. Egan, Raymond C. Rosen, Arthur L. Burnett, Xiao Ni, Minhyung Suh, Kevin T. McVary
Publikováno v:
Urology. 86:570-580
Objective To establish a descriptive profile of men with coexistent erectile dysfunction (ED) and/or benign prostatic hyperplasia (BPH), ED only or BPH only compared to those with neither condition and to identify the determinants of coexisting disea
Autor:
David G. Wong, R. Jonathan Henderson, Sebastian Zepeda, Sebastian Sorsaburu, Lars Viktrup, Adolfo Casabé, Claus G. Roehrborn, Carsten Henneges, Luigi F. Da Pozzo
Publikováno v:
Journal of Urology. 191:727-733
Purpose Medical treatment for men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia is 5α-reductase inhibitor monotherapy or coadministration with an α-blocker. We assessed the effects of tadalafi
Autor:
Russell Blair Egerdie, Stephen Auerbach, Martin Sanchez Garza, Anne Esler, Pierre Costa, David G. Wong, Claus G. Roehrborn, Roberta J. Secrest
Publikováno v:
The Journal of Sexual Medicine. 9:271-281
Introduction Erectile dysfunction (ED) and lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH-LUTS) commonly coexist in aging men. Tadalafil, a phosphodiesterase type 5 inhibitor approved for treating ED, is currently being
Autor:
Patrick R. Burns, Eusebio Rubio-Aurioles, Sheryl A. Kingsberg, David G. Wong, Stanley E. Althof, Haoyue Zeigler
Publikováno v:
Urology. 75:1358-1363
To evaluate the effect of tadalafil 5 mg taken once daily on efficacy (erection achievement and penetration) and overall sexual satisfaction in men with erectile dysfunction (ED) and their female partners.This retrospective analysis included data poo
Autor:
David G. Wong, Ridwan Shabsigh, H Zeigler, Craig F. Donatucci, Michael A. Perelman, Raymond A. Costabile, Patrick R. Burns
Publikováno v:
International Journal of Impotence Research. 22:1-8
The reliability of response to treatment is an important component of erectile dysfunction (ED) treatment. This study examined the reliability of tadalafil once daily (that is, successful attempts/total attempts) following initial successful intercou
Autor:
Patrick R. Burns, David G. Wong, Edward D. Kim, Raymond C. Rosen, Eusebio Rubio-Aurioles, Haoyue Zeigler, Harmut Porst
Publikováno v:
The Journal of Sexual Medicine. 6:1314-1323
Introduction Clinical research on erectile dysfunction (ED) has focused primarily on the male and the impact of treatment on their erectile function (EF) and sexual quality of life. However, ED affects the quality of life of both the male and the fem
Autor:
Sidney Glina, David G. Wong, Sebastian Sorsaburu, Sherie A. Dowsett, Craig F. Donatucci, Steven Watts, François Giuliano
Publikováno v:
Current Medical Research and Opinion. 24:3383-3392
To provide clinically relevant information on tadalafil 2.5 or 5 mg once daily for the treatment of erectile dysfunction (ED), by reviewing safety and efficacy study findings. Findings from an integrated analysis of trials of tadalafil 10 and 20 mg a
Autor:
Edward Kim, D. Muram, R. Shinghal, Fanni Natanegara, David G. Wong, Raymond C. Rosen, Ridwan Shabsigh
Publikováno v:
International Journal of Impotence Research. 20:554-560
The purpose of this post hoc analysis was to evaluate response to tadalafil in patients with erectile dysfunction (ED) who reported failures in all sexual intercourse attempts before treatment. In a multicenter, open-label study, 1911 men received ta
Autor:
Raymond C. Rosen, M. Suh, David G. Wong, Kevin T. McVary, Kathryn B. Egan, Arthur L. Burnett, Xiao Ni
Publikováno v:
International journal of clinical practice. 69(11)
Summary Objective The objective of this study was to investigate rural/urban and socio-demographic disparities in lower urinary tract symptoms and benign prostatic hyperplasia (LUTS/BPH) in a nationally representative population of men. Methods Data